• Users Online: 45439
  • Home
  • Print this page
  • Email this page
This article has been cited by
1Monthly Ranibizumab for Nonproliferative Macular Telangiectasia Type 2: A 12-Month Prospective Study
Peter Charbel Issa,Robert P. Finger,Kathrin Kruse,Sönke Baumüller,Hendrik P.N. Scholl,Frank G. Holz
American Journal of Ophthalmology.2011;151(5)876
[DOI]
2Macular telangiectasia type 2
Peter Charbel Issa,Mark C. Gillies,Emily Y. Chew,Alan C. Bird,Tjebo F.C. Heeren,Tunde Peto,Frank G. Holz,Hendrik P.N. Scholl
Progress in Retinal and Eye Research.2013;34(5)49
[DOI]
3Characterization of Idiopathic Choroidal Neovascularization Using Fluorescein Angiography, Indocyanine Green Angiography, and Optical Coherence Tomography Angiography
Atul Kumar,Rajpal Vohra,Surbhi Agrawal,Rohan Chawla,Shorya Vardhan Azad,Pradeep Venkatesh,Anu Sharma
Ophthalmic Surgery, Lasers and Imaging Retina.2018;49(7)516
[DOI]
4Optical coherence tomography-angiography for monitoring neovascularisations in macular telangiectasia type 2
Simone Tzaridis,Kristina Hess,Martin Friedlander,Frank G Holz
British Journal of Ophthalmology.2021;105(5)735
[DOI]
5Optical coherence tomography-angiography for monitoring neovascularisations in macular telangiectasia type 2
Peter Charbel Issa,Frank G. Holz
British Journal of Ophthalmology.2016;105(5)79
[DOI]
6BEVACIZUMAB (AVASTIN) THERAPY FOR IDIOPATHIC MACULAR TELANGIECTASIA TYPE II
JACLYN L. KOVACH,PHILIP J. ROSENFELD
Retina.2009;29(1)27
[DOI]
7EFFICACY OF ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY IN SUBRETINAL NEOVASCULARIZATION SECONDARY TO MACULAR TELANGIECTASIA TYPE 2
Raja Narayanan,Jay Chhablani,Manish Sinha,Vivek Dave,Mudit Tyagi,Rajeev R. Pappuru,Baruch D. Kuppermann
Retina.2012;32(10)2001
[DOI]
8Bevacizumab (Avastin) for the Treatment of Ocular Disease
Jonathan B. Gunther,Michael M. Altaweel
Survey of Ophthalmology.2009;54(3)372
[DOI]
9INTRAVITREAL BEVACIZUMAB FOR TREATMENT OF PROLIFERATIVE AND NONPROLIFERATIVE TYPE 2 IDIOPATHIC MACULAR TELANGIECTASIA
A Brock Roller,James C Folk,Narendra M Patel,H Culver Boldt,Stephen R Russell,Michael D Abramoff,Vinit B Mahajan
Retina.2011;31(9)1848
[DOI]
10Treatment Modalities for Idiopathic Macular Telangiectasia: An Evidence-Based Systematic Review of the Literature
Irini P. Chatziralli,Poonam K. Sharma,Sobha Sivaprasad
Seminars in Ophthalmology.2017;32(3)384
[DOI]
11Salient features and management options of macular telangiectasia type 2: a review and update
Anagha Vaze,Mark Gillies
Expert Review of Ophthalmology.2016;11(6)429
[DOI]

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal